Smith & Nephew Plc Share Price

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 16:35:18 17/06/2024 BST 5-day change 1st Jan Change
987.2 GBX -1.24% Intraday chart for Smith & Nephew Plc -3.88% -8.47%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 5.81B 459B Sales 2025 * 6.12B 484B Capitalization 11.05B 873B
Net income 2024 * 527M 41.62B Net income 2025 * 691M 54.57B EV / Sales 2024 * 2.35 x
Net Debt 2024 * 2.61B 206B Net Debt 2025 * 2.3B 181B EV / Sales 2025 * 2.18 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
16.5 x
Employees 18,452
Yield 2024 *
2.98%
Yield 2025 *
3.36%
Free-Float 99.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.65%
1 week-3.45%
Current month+0.12%
1 month-3.12%
3 months-5.79%
6 months-5.25%
Current year-8.06%
More quotes
1 week
990.80
Extreme 990.8
1 038.00
1 month
967.80
Extreme 967.8
1 046.50
Current year
946.00
Extreme 946
1 181.50
1 year
887.00
Extreme 887
1 269.00
3 years
887.00
Extreme 887
1 601.50
5 years
887.00
Extreme 887
2 023.00
10 years
881.00
Extreme 881
2 023.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/03/22
Director of Finance/CFO 56 11-30
Compliance Officer - 31/03/99
Members of the board TitleAgeSince
Director/Board Member 65 30/09/17
Director/Board Member 62 13/09/23
Chairman 63 25/04/23
More insiders
Date Price Change Volume
17/06/24 987.2 -1.24% 1 355 784
14/06/24 999.6 -1.13% 1,719,056
13/06/24 1,011 -0.44% 1,853,498
12/06/24 1,015 +0.69% 2,762,673
11/06/24 1,009 -1.80% 2,076,558

Delayed Quote London S.E., June 17, 2024 at 11:40 am

More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.68 USD
Average target price
16.45 USD
Spread / Average Target
+29.79%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW